Wholesaler Sues Sanofi-Aventis Over Arthritis Drug

Law360, New York (August 21, 2007, 12:00 AM EDT) -- A drug wholesaler has sought treble damages in a putative class action lawsuit against Sanofi-Aventis, accusing the French pharmaceutical giant of unlawfully blocking generic competition for Sanofi's rheumatoid arthritis treatment Arava by filing a sham Citizen Petition with the U.S. Food and Drug Administration.

Louisiana Wholesale Drug Co. Inc. filed the lawsuit on Friday in federal court in Manhattan, against Sanofi-Aventis, Sanofi-Aventis US LLC and Aventis Pharmaceuticals Inc.

The drug at issue in the suit is leflunomide, which is sold under the brand name Arava. AB-rated...
To view the full article, register now.